Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy

Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy

<p>Supplemental Figure S1. Mean pharmacokinetic profiles for single agent talazoparib (BMN673 in phase I clinical trial PRP-001) versus combination therapy.</p>

Na minha lista:
Detalhes bibliográficos
Autor principal: Zev A. Wainberg (15047031) (author)
Outros Autores: Arun S. Singh (15036660) (author), Gottfried E. Konecny (15047034) (author), Kelly E. McCann (15047037) (author), J. Randolph Hecht (15047040) (author), Jonathan Goldman (15047043) (author), Bartosz Chmielowski (15036666) (author), Richard S. Finn (10431048) (author), Neil O'Brien (15047046) (author), Erika Von Euw (15047049) (author), Megan M. Price (15047052) (author), Diego Martinez (15047055) (author), Lisa Yonemoto (15047058) (author), Meghan Brennan (15047061) (author), John A. Glaspy (15047064) (author), Dennis J. Slamon (15047067) (author)
Publicado em: 2025
Assuntos:
Cancer
Therapeutic Research and Development
Clinical Research and Trials
Methods and Technology
Clinical Trial Results
Phase I clinical trials
Drug Targets
Oncoprotein & tumor suppressor drug targets
Preclinical Models
In vitro models of cancer
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados